BACKGROUND & AIMS:
Metaplasias often have characteristics of developmentally related tissues. Pancreatic metaplastic ducts are usually associated with pancreatitis and pancreatic ductal adenocarcinoma. The tuft cell is a chemosensory cell that responds to signals in the extracellular environment via effector molecules. Commonly found in the biliary tract, tuft cells are absent from normal murine pancreas. Using the aberrant appearance of tuft cells as an indicator, we tested if pancreatic metaplasia represents transdifferentiation to a biliary phenotype and what effect this has on pancreatic tumorigenesis. METHODS: We analyzed pancreatic tissue and tumors that developed in mice that express an activated form of Kras (Kras LSLÀG12D/þ ;Ptf1a
Cre/þ mice). Normal bile duct, pancreatic duct, and tumor-associated metaplasias from the mice were analyzed for tuft cell and biliary progenitor markers, including SOX17, a transcription factor that regulates biliary development. We also analyzed pancreatic tissues from mice expressing transgenic SOX17 alone (ROSA tTa/þ ;Ptf1
CreERTM/ þ ;tetO-SOX17) or along with activated Kras (ROSAtT a/þ ;Ptf1a-CreERTM/þ ;tetO-SOX17;Kras LSL-G12D;þ ). RESULTS: Tuft cells were frequently found in areas of pancreatic metaplasia, decreased throughout tumor progression, and absent from invasive tumors. Analysis of the pancreatobiliary ductal systems of mice revealed tuft cells in the biliary tract but not the normal pancreatic duct. Analysis for biliary markers revealed expression of SOX17 in pancreatic metaplasia and tumors. Pancreasspecific overexpression of SOX17 led to ductal metaplasia along with inflammation and collagen deposition. Mice that overexpressed SOX17 along with Kras G12D had a greater degree of transformed tissue compared with mice expressing only Kras G12D . Immunofluorescence analysis of human pancreatic tissue arrays revealed the presence of tuft cells in metaplasia and early-stage tumors, along with SOX17 expression, consistent with a biliary phenotype. CONCLUSIONS: Expression of Kras G12D and SOX17 in mice induces development of metaplasias with a biliary phenotype containing tuft cells. Tuft cells express a number of tumorigenic factors that can alter the microenvironment. Expression of SOX17 induces pancreatitis and promotes Kras G12D -induced tumorigenesis in mice.
Keywords: Pancreatic Cancer; Pathogenesis; Mouse Model; Signal Transduction. P ancreatic ductal adenocarcinoma (PDA) is currently the fourth leading cause of cancer death, with an overall 4-year survival rate of 6% and an abysmal median survival of just 4 to 6 months. 1 Because symptoms appear late in disease progression and metastasis has typically occurred by the time of diagnosis, earlier detection is likely to be invaluable. Elucidation of early detection markers requires a greater understanding of early disease pathology, such as pancreatic intraepithelial neoplasia (PanIN), a proposed precursor to PDA, and acinar-to-ductal metaplasia (ADM), a process that results in the formation of highly reactive metaplastic ducts. The consistent association of ADM with PDA suggests that lesions arise as a consequence of disruption of nearby normal tissue. Recent studies implicate them as a source of PanIN. 2, 3 Consistent with this, metaplastic ducts are a hallmark of chronic pancreatitis, which may be part of the reason why chronic pancreatitis is a significant risk factor for PDA.
Epithelial metaplasia is a hallmark of inflammatory and neoplastic disease in several organs. In many tissues, normal epithelium is replaced by epithelium usually confined to a developmentally related organ; this phenomenon occurs in adenocarcinoma of the esophagus in areas of Barrett's metaplasia, where the epithelium takes on gastric and intestinal characteristics marked by CDX2 expression, or cystitis glandularis, where bladder metaplasia becomes phenotypically colon-like. 4 In the pancreas, ADM is generally described as pancreatic acinar cells being replaced by pancreatic duct cells, with no prior description of their mimicry of epithelia of related tissues.
One cell type absent from the exocrine pancreas is the tuft cell. Tuft cells are a type of solitary chemosensory cell and are found in multiple organs but are prevalent in the developmentally related common bile duct and murine pancreatobiliary duct (the segment of duct following the intersection of the main pancreatic duct and the bile duct before fusion with the duodenum) and associated peribiliary glands (PBGs). Solitary chemosensory cells are part of the diffuse chemosensory system and are analogous to taste cells, although they do not aggregate in buds. Solitary chemosensory cells are believed to link chemosensation of intraluminal content to local control of absorptive and secretory processes as well as central nervous system activity. 5 In our analysis of pancreatic metaplasia, we have discovered that the aberrant genesis of pancreatic tuft cells is common in Kras G12D -induced pancreatic disease and is accompanied by epithelial expression of SOX17, a master control factor of biliary development and differentiation. 6 Lineage tracing showed that pancreatic tuft cells transdifferentiate from adult acinar cells and express a full array of markers associated with mature tuft cells found in other tissues. ADM and murine PanINs (mPanINs) consistently contained a PDX1
þ cell population reminiscent of the common pancreatobiliary progenitor. 6 Forced expression of SOX17 in adult pancreas was sufficient to induce acinar cell transdifferentiation into a tuft cell-containing metaplasia, accompanied by a chronic pancreatitis-like phenotype, including fibrosis and an adaptive immune response. Transgenic expression of SOX17 in concert with oncogenic K-ras expression enhanced the degree of transformation of normal pancreas, suggesting that SOX17-induced metaplasia was fully susceptible to Kras-induced transformation. We conclude that pancreatic ADM found in PDA represents transdifferentiation to a biliary phenotype and contributes to disease progression through the assumption of a pancreatobiliary progenitor cell phenotype.
Materials and Methods

Mouse Strains
Cre-ERTM/þ , tetO-SOX17, MTTgfa, and ROSA tTa/þ strains have been described previously and were genotyped accordingly. [7] [8] [9] [10] [11] [12] ROSA YFP mice were obtained from Jackson Laboratories (Bar Harbor, ME). Experiments were conducted in accordance with the Office of Laboratory Animal Welfare and approved by the institutional animal care and use committees at Stony Brook University and the Mayo Clinic.
Mouse Tissue Microarrays
Custom 5-mm tissue microarrays were assembled by a hand corer and precast recipient molds. PDAs from 10 LSLKras G12D ;P53 R172H/þ ;PDX1 Cre/þ mice were included. Adjacent PanIN-containing tissues were included for 5 tumors, and distant metastases from several organ sites were included for 5 other tumors.
Human Samples
Distribution and use of all human samples was approved by the institutional review boards of Vanderbilt University Medical Center and the Mayo Clinic.
Induction of Experimental Pancreatitis
Cerulein-induced pancreatitis was achieved by treating mice twice daily with 250 mg/kg cerulein (Sigma-Aldrich, St Louis, MO) for 7 days and allowing mice to recover for 1 day. Metaplasia was induced in the MT-Tgfa strain by administration of 25 mmol/L ZnSO 4 in drinking water for 3, 6, or 9.5 months.
Overexpression of SOX17
Adult acinar cell-specific overexpression of SOX17 was accomplished by treating 6-to 12-week-old mice with 5 daily doses of 5 mg/kg tamoxifen administered through oral gavage to ROSA tTa/þ ;Ptf1a
CreERTM/þ ;tetO-SOX17 mice with 6 weeks of recovery. The identical protocol was used with ROSA tTa/þ ; Ptf1a
CreERTM/þ ;tetO-SOX17;Kras LSL-G12D;þ mice. Tumor quantitation was performed by scanning 4 random H&E-stained slides from each pancreata with an Aperio slide scanner (Vista, CA). Aperio ImageScope software was used to delineate and quantitate areas flanked by fibrosis and containing metaplasia or neoplasia compared with total tissue area.
Immunostaining
Tissues were harvested and fixed overnight in 4% paraformaldehyde. Immunohistochemistry (IHC) was performed as previously described. 13 Slides were counterstained with hematoxylin and photographed on an Olympus BX41 light microscope (Olympus, Tokyo, Japan). Immunofluorescence (IF) was performed as previously described with some modifications (Supplementary Methods). 14 
Electron Microscopy
Tissue was prepared for electron microscopy by perfusion of mice with 2% paraformaldehyde/2.5% electron microscopy-grade glutaraldehyde in 0.1 mol/L phosphate-buffered saline, pH 7.4. Samples were viewed with a Tecnail2 BioTwinG 2 transmission electron microscope (FEI, Hillsboro, OR) at 80 kV. Digital images were acquired with an XR-60 CCD digital camera system (Advanced Microscopy Techniques, Woburn, MA).
Quantitation of Tuft Cells
DCLK1 IHC was performed on paraffin-embedded tissue from 11 LSL-Kras G12D ;Ptf1a Cre/þ mice ranging in age from 4 months to 1 year using a Discovery XT autostainer (Ventana Medical Systems, Tuscon, AZ). A minimum of 20 images at 40Â were acquired per slide and lesions staged. Tuft cells were quantitated as DCLK1 þ cells per number of nuclei per lesion.
For quantitation in MT-Tgfa mice, DCLK1 IHC was performed on paraffin-embedded tissue from 9 mice treated with ZnSO 4 from 3 to 10 months. Ten images were taken at 40Â per slide, and tuft cells were quantitated as DCLK1 þ cells per number of nuclei per metaplastic lesion.
Lineage Tracing
Recombination was induced in 8-week-old Kras G12D/þ ; ROSA YFP ;Ptf1a Cre-ERTM/þ mice with one daily intraperitoneal injection of 3 mg tamoxifen (Sigma-Aldrich) for 5 days. Tumorigenesis was accelerated by a daily intraperitoneal injection of 250 mg/kg cerulein for 5 days. Mice were killed 9 weeks later, and tissue was prepared for IF.
Cell Culture
Human PDA cell lines were purchased from American Type Culture Collection (Manassas, VA) and maintained at 37 C in 5% CO 2 in American Type Culture Collection-recommended medium supplemented with 10% fetal bovine serum and 0.5 mg/mL gentamicin.
Western Blotting
Preconfluent cells were harvested in ice-cold RIPA buffer supplemented with PhosSTOP phosphatase inhibitor and cOmplete EDTA-free protease inhibitor (Roche, Indianapolis, IN). A total of 75 mg protein was run on a 7% sodium dodecyl sulfate gel and blotted to polyvinylidene difluoride membrane for antibody incubation.
Results
Tuft Cells Are a Consistent Component of Epithelial Metaplasia in a Mouse Model of Pancreatic Tumorigenesis
The LSL-Kras G12D/þ ;Ptf1a
Cre/þ murine model of pancreatic tumorigenesis presents with mainly ductal metaplasia and early mPanINs up to w1 year of age, when later-stage mPanINs and occasionally PDA is found. The epidermal growth factor receptor (EGFR) pathway has been associated with progression of PDA, and recently we found that activity 
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Biliary Metaplasia in Pancreas Tumorigenesiswas required for induction of tumorigenesis. 3, 15 On examining EGFR pathway activity by IF in this model, we observed significant cellular heterogeneity within metaplastic structures. Although EGFR activity was elevated throughout the metaplastic epithelium, we found highly elevated positivity for pY1068 EGFR, pY416 Src, pT202/ pY204 ERK, and the EGFR ligand transforming growth factor a within isolated cells of metaplastic ducts ( Figure 1A ). This staining pattern was never observed in ducts of wild-type control pancreata but could readily be identified in the nearby pancreatobiliary tract (data not shown). Using phalloidin to costain for F-actin, we noted that these phospho-EGFR-positive cells had a unique arrangement of microfilaments, marked by a perpendicular orientation to the apical membrane, typical of a tuft cell. IF for villin and acetylated a-tubulin confirmed the presence of both prominent microvilli and the tubulovesicular system, respectively ( Figure 1B) . Using the unique microfilament arrangement as a guide, electron microscopy of a 4-month-old LSL-Kras G12D/þ ; Ptf1a
Cre/þ pancreas confirmed that tuft cells were commonly integrated into metaplastic ducts ( Figure 1C) . Doublecortin-like kinase 1 (DCLK1), a tubulin polymerization serine/threonine kinase, has been proposed to be both a marker of quiescent stem cells in the pancreas as well as a marker of tuft cells in the stomach and intestine, where they are believed to represent a terminally differentiation cell population. [16] [17] [18] To address whether metaplastic tuft cells phenocopy mature tuft cells in other organs, DCLK1 expression was assessed relative to the expression level of other tuft cell markers. Co-IF with phalloidin revealed that 100% of tuft cells expressed DCLK1 (n ¼ 300), whereas 72% of DCLK1-positive cells were identified unambiguously as tuft cells (n ¼ 418; Figure 1D ). The remaining 28% of DCLK1-positive cells that were not obviously tuft cells were possibly obscured due to section planarity or, alternatively, represent a legitimate non-tuft cell population, such as an adult stem cell population identified previously. Tuft cells of the normal biliary and intestinal tract have been shown to express an array of markers, including G-a-gustducin, TRPM5, b-endorphin, cyclooxygenase (COX)-1, COX-2, HPGDS, and Gfi1b (Supplementary Table 1 ). We found that metaplastic pancreatic tuft cells expressed each of these proteins at highly elevated levels, confirming their identity as bona fide tuft cells, indistinguishable from those found in normal tissue 16, [19] [20] [21] (Supplementary Figure 1) . To determine the association of tuft cells with disease progression, we quantitated the number of DCLK1 þ tuft cells at different points in tumor progression using pancreata from LSL-Kras G12D ;Ptf1a Cre/þ mice of various ages. Tuft cells were most abundant in ADM (an average 15.0% of the epithelium per lesion) and became less frequent throughout disease progression, constituting 11.2% of the epithelium in mPanIN-1, 8.7% in mPanIN-2, and 2.9% in mPanIN-3, whereas invasive disease had no tuft cells ( Figure 1E ). Analysis of pancreata from the LSLKras G12D ;p53 R172H/þ ;Pdx1-Cre model of PDA was consistent with these results, although the overall number of cells per lesion was generally reduced to 4.8% in PanIN-1s, 2.1% in PanIN-2s, and <1% in PanIN-3s, with several being entirely negative ( Figure 1F ). To determine if tuft cells accompanied nontumor models of pancreatic metaplasia, we examined DCLK1 expression in transforming growth factor a-driven and cerulein-induced metaplasia. Tuft cells were very commonly associated with metaplasia in MT-Tgfa mice, present in 73.5% of metaplastic lesions, constituting 14.4% of the epithelium (Supplementary Figure 2A) . The presence of tuft cells was confirmed by electron microscopy (Supplementary Figure 2B) . Interestingly, tuft cells were rarely found in cerulein-induced transient metaplasia (Supplementary Figure 2C) .
Metaplastic Tuft Cells Suggest Adoption of a Biliary Phenotype
Tuft cells have been previously described within the normal murine biliary tract and intestine; however, in our experiments, we never observed these cells in random sections of wild-type pancreata. 16, 22 To definitively determine if the normal main pancreatic duct harbored a tuft cell population, we dissected the main pancreatic duct away from the common duct of the biliary tract and the pancreatobiliary duct and examined them histologically. The murine biliary tract was composed of a central duct decorated along its length by ancillary peribiliary glands (PBGs), which were lined with columnar epithelium, including numerous tuft cells, identified by DCLK1 IHC. 23 In contrast, the murine main pancreatic duct was composed of low cuboidal epithelium, lacked PBGs, and was entirely devoid of tuft cells. The pancreatobiliary duct was morphologically similar to the bile duct, including PBGs and numerous tuft cells (Figure 2A ).
Pancreatic Tuft Cells Transdifferentiate From Acinar Cells
PBGs associated with the common and pancreatobiliary ducts (Figure 2A ) have been hypothesized to be a source of progenitor cells for the liver, biliary tract, and pancreas, in part due to their expression of several stem and progenitor markers. 23 Strobel et al have labeled related structures associated with the main pancreatic duct as "pancreatic duct glands" (PDGs), describing them as a potential source of pancreatic disease. 24 In this study, it is hypothesized that ADM may directly emanate from the expansion of PDGs, with a popular alternative being that acinar cells transdifferentiate to form metaplasia. To distinguish these possibilities in our system, we conducted lineage tracing in the LSL-Kras G12D/þ ;ROSA YFP ;Ptf1a Cre-ERTM/þ murine model. This model initiates expression of both Kras G12D and yellow fluorescent protein (YFP) exclusively in Ptf1a þ adult acinar cells upon tamoxifen induction of CRE activity. 8 YFP fluorescence was found in 68.7% of tuft cells identified by phalloidin staining (n ¼ 300) and 76.3% of DCLK1 þ cells (n ¼ 300) (Figure 2B ), indicating that they are commonly derived from transdifferentiation of acinar cells. YFPnegative tuft cells could represent partial derivation from normal PDGs, incomplete recombination of the ROSA locus, or ROSA promoter activity silencing, as has been observed in other adult tissues. 25 We conclude that while Krasinduced metaplasia is not primarily derived from PDGs, it does take on a PDG-like phenotype, including their possible regenerative function.
Pancreatic Metaplasia Takes on a Pancreatobiliary Progenitor Phenotype
Metaplasia has been described as a developmental reversion, taking on the phenotype of cells normally confined to other developmentally related organs. 4 Recent studies have shown that the murine biliary tract is developmentally more closely related to the pancreas, sharing a common progenitor cell population. 6 The observation that ADM resembles tuft cell-containing PBGs led us to hypothesize that ADM adopts other characteristics of the biliary tract. To test this, we examined the expression of SOX17, a transcription factor critical for bile duct development and recently described as being expressed in human intraductal papillary mucinous neoplasms. The pancreas and biliary tract share a common progenitor cell population characterized by coexpression of PDX1 and SOX17. In the adult, however, epithelial SOX17 expression is restricted to the biliary tract, although endothelial SOX17 can be found lining blood vessels 6 (Supplementary Figure 3) . Co-IF for SOX17 and PDX1 revealed 2 cell subtypes within metaplastic ducts: a PDX1 þ SOX17 À population and a PDX1 þ /SOX17 þ population ( Figure 3A) ; the latter is reminiscent of the common pancreatobiliary progenitor cell. 6 To determine if this expression pattern persisted, LSL-Kras
Cre/þ mice of various ages were assessed for SOX17 expression by IHC. The frequency and intensity of SOX17 expression increased throughout disease progression over time in PanINs of all stages. Like tuft cells, SOX17 was absent from invasive disease ( Figure 3B ). Interestingly, liver metastases from both the Kras G12D/þ ;Ptf1a
Cre/þ and LSL-Kras
G12D
;P53 R172H/þ ; Pdx1-Cre models often expressed SOX17, suggesting reversion to a more differentiated phenotype (data not shown). SOX17 was not expressed in transient metaplastic ducts induced by long-term treatment with cerulein (data not shown).
The apparent inverse relationship between increasingly common SOX17 expression and the gradual loss of tuft cells in the mPanINs of Kras G12D/þ ;Ptf1a
Cre/þ mice led us to examine their possible causal relationship more directly. We performed co-IF for SOX17 and DCLK1 on 4-month-old Kras G12D/þ ;Ptf1a-Cre/þ pancreata. Interestingly, DCLK1
þ tuft cells consistently expressed relatively low levels of SOX17 compared with most other cells in the metaplastic epithelium ( Figure 3C ), indicating that elevated levels of SOX17 are not required and may have to Cre/þ ;SOX17 OE mouse, where SOX17 has been overexpressed from development, and a Ptf1a
CreERTM/þ ;SOX17 OE mouse in which SOX17 expression was induced in the adult. The pancreata of both experimental models exhibit a biliary-like phenotype highly expressing SOX17 and DCLK1 þ tuft cells.
Consistent with biliary differentiation, PDX1 expression is low in the Ptf1a
Cre/þ ;SOX17 OE model. Consistent with metaplasia, the Ptf1a
CreERTM/þ ;SOX17 OE model highly expresses PDX1. Exhibiting characteristics of chronic pancreatitis, both models show an innate (F4/80) and adaptive (CD3) immune response accompanying a fibrotic response (picrosirius) and proliferative (Ki67) ducts. Scale bars ¼ 200 mm (H&E and picrosirius), 100 mm (IHC), and 25 mm (insets). Asterisks indicate areas depicted in the insets.
be suppressed for the derivation or maintenance of metaplastic tuft cells. PDX1 expression was found in some, but not all, DCLK1 þ tuft cells, suggesting no relationship with tuft cell maintenance ( Figure 3D ). SOX17 þ PBGs are mucinous, tuft cell-containing glands that express stem cell factors such as OCT4 and LGR5 and endoderm-specific markers SOX9, PDX1, EPCAM, CXCR4, and FOXA2. 23 Many of these markers have been previously described to play a role in pancreatic ADM and tumorigenesis. 2, [27] [28] [29] [30] [31] To examine the extent of PBG mimicry in acinar cell-derived metaplasia, we induced Kras G12D expression by treating 8-week-old LSL-Kras G12D ; ROSA YFP ;Ptf1a Cre-ERTM/þ mice with tamoxifen to induce recombination and cerulein to accelerate tumorigenesis and examined their pancreata 9 weeks later. We found that this acinar cell-derived pancreatic metaplasia widely expressed SOX17, PDX1, SOX9, EPCAM, and LGR5, consistent with a PBG-like phenotype (Supplementary Figure 3) .
SOX17 Expression Drives a Pancreatitis-like Disease State and Accelerates Kras-Driven Tumorigenesis
SOX17 is a known determinant of biliary development and differentiation. Its presence in pancreatic metaplasia suggests that it may play a causal role in acinar cell reprogramming during disease. It has been shown previously that SOX17 overexpression in PDX1 þ cells during early pancreatic development causes severe ductal expansion. Using a similar model that induces a more universal pancreatic expression of SOX17, ROSA tTa/þ ;Ptf1a Cre/þ ;tetO-SOX17 (Ptf1a Cre/þ ;SOX17 OE ) and an adult acinar cell-specific inducible model of SOX17 overexpression, ROSA tTa/þ ; Ptf1a
CreERTM/þ ;tetO-SOX17 (Ptf1a CreERTM/þ ;SOX17 OE ), we set out to determine the full spectrum of downstream consequences of SOX17 expression in the pancreas. In the Ptf1a
Cre/þ ;SOX17 OE model, mice express SOX17 in Ptf1a þ -positive progenitor cell populations and exhibit an expansion of PDX1-positive, tuft cell-containing ductal structures at the expense of the acinar and islet compartments by 6 weeks of age (Figure 4) , consistent with previous findings. 6 We found that ductal structures were constituted by Ki67-positive epithelia and contained a subpopulation of DCLK1 þ tuft cells, consistent with Kras-induced ADM and the assumption of a biliary phenotype, respectively. Surprisingly, these pancreata showed a robust innate and adaptive inflammatory reaction, as determined by IHC for macrophages (F4/80 þ ) and T cells (CD3 þ ). Picrosirius red staining showed a vigorous fibrotic response (Figure 4) .
To determine whether SOX17 was capable of reprogramming adult acinar cells, we induced SOX17 expression in the pancreata of adult mice using the Ptf1a
CreERTM/þ ; SOX17 OE model. Five-to 10-week-old mice were treated with tamoxifen to induce acinar cell-specific CRE activity, Figure 5 . SOX17 expression facilitates Kras G12D -driven tumorigenesis. Immunohistochemical comparison of the pancreata from a wild-type mouse to that of a Kras G12D ;Ptf1a
CreERTM/þ ;ROSA tTa/þ mouse and a Kras G12D ;Ptf1a
CreERTM/þ ;SOX17 OE mouse treated with tamoxifen and allowed to recover for 6 weeks. In concert with Kras G12D , overexpression of SOX17 leads to a greater degree of transformed tissue, as identified in H&E, characterized by PDX1 expression and DCLK1 þ tuft cells. Scale bars ¼ 200 mm (H&E), 100 mm (IHC), and 25 mm (insets). Asterisks indicate areas depicted in the insets.
leading to tetracycline transactivator induction of SOX17 in these cells. Similar to what we observed with SOX17 expression initiated during organogenesis, expression of SOX17 for 6 weeks in adult acinar cells induced a PDX1 þ metaplasia in which 10.8% of the epithelium was composed of DCLK1 þ tuft cells, mimicking a pancreatobiliary progenitor cell phenotype and confirming a role for SOX17 in tuft cell genesis. The robust stromal reaction included innate and adaptive inflammatory responses ( Figure 4) and fibrosis, consistent with a chronic pancreatitis phenotype, but no PanIN formation as determined by Muc5aC IHC (Supplementary Figure 4) . Taken together, our data indicate that epithelial overexpression of SOX17 was sufficient to drive a stable phenotype recapitulating all major aspects of chronic pancreatitis, a known risk factor for pancreatic tumorigenesis, in the absence of overt tissue damage.
We then hypothesized that SOX17-induced ADM would collaborate with Kras G12D expression, accelerating the relatively inefficient metaplastic process induced by Kras G12D alone. To test this, we treated 5-to 10-weekold ROSA tTa/þ ;Kras LSL-G12D/þ ;Ptf1a CreERTM/þ ;tetO-SOX17 mice (Kras G12D ;Ptf1a
CreERTM/þ ;SOX17 OE ) with tamoxifen, which initiates coexpression of Kras G12D and SOX17 in adult acinar cells, and allowed them to recover for 6 weeks. Compared with expression of Kras G12D alone, which ranged from 5% to 12% of total tissue replacement by PanIN-containing regions, concomitant SOX17 expression led to a virtually complete replacement of the normal acinar cell compartment with PanIN together with reactive epithelia and stroma. Tumors were characterized by PDX1 expression and DCLK1 þ tuft cells ( Figure 5 ). IHC for the PanIN marker, Muc5aC, confirmed that SOX17 expression did not affect the type of tumors formed in these mice (Supplementary Figure 4) and pathology showed no indication of advanced progression, with the majority of tumors in early PanIN-1/2 stage. These data indicate that SOX17-induced biliary metaplasia is highly susceptible to Kras G12D transformation and, as such, can drive initiation of pancreatic disease.
Human Pancreatic Disease Assumes a Biliary-like Phenotype
To determine if human pancreatic disease resembles progression seen in murine models, we assessed human SOX17 expression was also examined in these pancreas tissue microarrays. Although staining in general was less intense compared with murine tissue, 78% (39/50) of PanIN-1s, 80% (24/30) of PanIN-2s, 93% (25/27) of PanIN-3s, and 30% of PDAs (14/47) expressed SOX17, although there were relatively few cells in the PDA samples ( Figure 6B ). Thirty-one percent of chronic pancreatitis samples had SOX17-positive cells, and 6% (5/79) of normal pancreas samples showed positivity confined to large normal ducts.
To confirm SOX17 expression in human PDA, a panel of PDA cell lines was assessed for SOX17 expression by Western blot. Although expression levels of the isoforms varied, 9 of 12 PDA cell lines expressed detectable levels of SOX17 ( Figure 6C ).
Discussion
Pancreatic metaplastic ductal lesions represent a transdifferentiation event and are hypothesized to be preneoplastic. Our work shows that Kras G12D -induced ADM presents as an epithelium that assumes several characteristics of the developmentally related bile duct, marked by the presence of numerous tuft cells and SOX17 expression. This tissue-switching phenomenon, a previously unrecognized process in the pancreas, reinforces the wellestablished concept that metaplasia is composed of cell types phenotypically similar to those normally restricted to tissues derived from a neighboring region of the embryo. 4 We found that SOX17 expression alone, limited to adult acinar cells, was sufficient to induce a stable metaplastic change that included genesis of tuft cells and coexpression of PDX1, the latter being suggestive of reprogramming akin to a pancreatobiliary progenitor cell. SOX17 overexpression combined with expression of oncogenic Kras G12D leads an enhancement of tumor initiation compared with Kras G12D expression alone, consistent with the metaplastic change being a prerequisite for pancreatic tumorigenesis.
Although enhanced metaplasia is one explanation for accelerated tumorigenesis, SOX17 expression also induced a dramatic, concurrent stromal response reminiscent of chronic pancreatitis. Chronic pancreatitis is a known risk factor for PDA, and several studies have shown that the desmoplastic and inflammatory responses can contribute to pancreatic tumor progression. 32 The ability of SOX17 overexpression to induce this stromal reaction may contribute to the initial epithelial response. However, we favor a model in which the stromal response and susceptibility to transformation are consequences of biliary reprogramming rather than the converse. During examination of Kras G12D or SOX17-induced metaplasia for proinflammatory signals, for instance, we found that key components of the prostaglandin synthesis pathway, including HPGDS, COX-1, and COX-2, the latter of which is a known contributor to pancreatic disease, 33 were expressed at very high levels in metaplastic tuft cells. The identification of these cells as chemosensory is suggestive of a role in detection of injury and initiation of a repair response. Consistent with this, tuft cells also express progenitor cell markers such as LGR5 and DCLK1 (Itzkovitz et al 34 and data not shown), which could aid in tissue repair. Interestingly, pancreatic tuft cells have been proposed to act as tumor-initiating cells when they are engineered to express oncogenic KRAS, which may usurp their putative regenerative function (Steven Leach, personal communication, June 2012).
The role of SOX17 in pancreatic metaplasia is somewhat reminiscent of what was recently observed in mice overexpressing SOX9, a related transcription factor. 2 In the previous study, SOX9 was not capable of hijacking acinar cell differentiation when expressed during organogenesis, as was SOX17, suggesting a unique reprogramming activity for SOX17 in pancreatic progenitors. Conversely, although SOX9 appears to be critical for stabilization of pancreatic metaplasia, we found that administration of doxycycline to turn off SOX17 expression after metaplasia forms did not lead to collapse of metaplastic ducts (data not shown). Thus, SOX17 and SOX9 appear to have similar but distinct functions in pancreatic disease.
We conclude that SOX17 expression itself is sufficient to drive formation of tuft cell-containing, proinflammatory, ductal reprogramming of pancreatic acinar cells in vivo. We found that this metaplasia is accompanied by a dramatic stromal response in the absence of further manipulation. Finally, when combined with Kras G12D expression, SOX17 overexpression enhanced tumorigenesis, suggesting that SOX17 expression and the ensuing biliary transdifferentiation promotes tumor formation.
